Meet Inven2 at the Nordic Life Science Days

NLS-dagene stand
Inger Sandlie, Torleif Tollefsrud Gjølberg, Simone Mester and Jan Terje Andersen are the entrepreneurs behind Authera. Photo: Holst&Paulsen
28. November 2023
The Nordic Life Science Days is the largest partnering conference for life sciences in the Nordic countries. Inven2 will participate with a joint Norwegian stand and in meetings with the industry to promote innovation projects from our portfolio. Feel free to contact us at the conference.

 

Nordic Life Science Days brings together about 1,500 participants from the Nordic region and the rest of the world in Copenhagen on the 29th and 30th of November.

This year, eight employees from Inven2 will attend the Nordic Life Science Days. Their primary goal is industry collaboration and partnering meetings to promote innovation projects they are commercializing on behalf of researchers at the University of Oslo and South-Eastern Norway Regional Health Authority.

‘Nordic Life Science Days is an important conference for Inven2. We meet relevant people from the international pharmaceutical industry and investors, and establish contacts that we can benefit from in other projects as well,’ says Jens Halvard Grønlien, VP of Innovation at Inven2.

In this overview, you can see which licensing opportunities Inven2’s employees are bringing to the NLS Days.

 

Joint Norwegian Stand

The Norwegian life science community has a joint stand to promote the Norwegian life science environment, and under the auspices of the Norwegian embassy in Copenhagen, a lunch is arranged at the embassy to promote cooperation between Norway and Denmark in the field.

The ones on the stand together are Oslo Cancer Cluster, Inven2, The Life Science Cluster, LMI, Senter for Digitalt Liv, NorTrials/Oslo University Hospital, Curida Diatec AS, Aleap, Norway Health Tech, and Innovation Norway.

If you want to get in touch with any of Inven2’s employees to learn more about one or more of our projects, come by the Norwegian stand.

Read more: